Gland Pharma
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · India · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Iv Pashamylaram V Patancheru M Sangaredd...Phone Number
+91 4030510999Website
www.glandpharma.comRevenue
$642.6 MillionStock Symbol
GLANDIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Gland Pharma
Gland Pharma Limited is a rapidly growing global manufacturer of generic injectables, supplying to markets including the United States, Europe, Canada, Australia, and India. The company specializes in complex injectables, oncology, and ophthalmics, leveraging its robust R&D and manufacturing capabilities. Established in 1978 in Hyderabad, India, Gland Pharma has expanded its operations to over 60 countries, focusing on a business-to-business model. With a commitment to high-quality and affordable products, Gland Pharma aims to meet diverse injectable needs across the pharmaceutical industry.Explore more
Gland Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gland Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Gland Pharma is spiking on competitors!
Funding: Get notified immidiatlly once Gland Pharma has new funding data
Earning: See what the market has to say on Gland Pharma recently announced quarterly report
Click to see if Gland Pharma had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Gland Pharma launches new products
Gland Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Gland Pharma
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Gland Pharma has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Gland Pharma
Find more new buyers
Company Profile Activity
Activity Insights
Gland Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Gland Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gland Pharma.
Gland Pharma financials insights
Gather financial insights about Gland Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Unspecified
$200M
Gland Pharma Tech Stack
A closer look at the technologies used by Gland Pharma
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Product Launch
Gland Pharma announced that its partner has received approval for liraglutide in the US, and the company is ready for the US launch in Q3 FY 2026.
Product Launch, Pharmaceuticals
Facilities Relocation / Expansion
Gland Pharma is investing in a new high-capacity ampoule line at Fontenay, adding 30 million in capacity by 2027. This will strengthen the position of the site on the market as the largest ampoule manufacturing site in Europe.
Spending/Investment, Capacity Planning, Manufacturing Operations
Facilities Relocation / Expansion
Spending/Investment, Capacity Planning, Warehouse Operations
Gland Pharma News & Media
Apotex Announces FDA Approval of First Generic Infuvite® Adult Injection (Single Dose Vial and Pharmacy Bulk package) with 180‑Day CGT Exclusivity for the Pharmacy bulk package in Partnership with Orbicular and Gland Pharma
WESTON, Fla., April 14, 2026 /PRNewswire/ - Apotex Corp., in partnership with Orbicular Pharmaceutical Technologies Pvt. Ltd. and Gland Pharma Limited, today announced that the U.S. Food and Drug Administration (FDA) has approved two Abbreviated New Drug Application (ANDA) for generic...Gland Pharma Shares Surge After Announcing Strong Q3FY26 Results
The Cenexi business segment also showed positive trends, with Q3 FY26 revenue reaching EURO 50 million, a 39 per cent increase year-on-year.Gland Pharma Announces Retirement of Chief Operating Officer Satnam Singh Loomba
Gland Pharma Limited has announced the retirement of Chief Operating Officer Mr. Satnam Singh Loomba, effective March 31, 2026, due to superannuation. Mr. Loomba, who joined the company on May 01, 2024, will also cease to be Senior Management Personnel from the retirement date. The Board of Directors has acknowledged his leadership and contributions during his tenure. The announcement was made in compliance with SEBI Regulation 30 requirements to both BSE and NSE exchanges.Gland Pharma Limited Announces Chief Executive Officer Changes, Effective from January 15, 2025
Gland Pharma Limited informed that based on the recommendation of the Nomination and Remuneration Committee, the Board has approved the appointment of Mr. Shyamakant Giri, as the new Chief Executive...
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Gland Pharma
Sign Up For FreeTo access detailed company insights
Gland Pharma Limited is a rapidly growing global manufacturer of generic injectables, supplying to markets including the United States, Europe, Canada, Australia, and India. The company specializes in complex injectables, oncology, and ophthalmics, leveraging its robust R&D and manufacturing capabilities. Established in 1978 in Hyderabad, India, Gl... Read More
